Switch to:
Also traded in: Argentina, Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.34
NYSE:CAH's Cash-to-Debt is ranked lower than
65% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.65 vs. NYSE:CAH: 0.34 )
Ranked among companies with meaningful Cash-to-Debt only.
NYSE:CAH' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.03  Med: 0.49 Max: 3.34
Current: 0.34
0.03
3.34
Equity-to-Asset 0.18
NYSE:CAH's Equity-to-Asset is ranked lower than
83% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.42 vs. NYSE:CAH: 0.18 )
Ranked among companies with meaningful Equity-to-Asset only.
NYSE:CAH' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.18  Med: 0.35 Max: 0.43
Current: 0.18
0.18
0.43
Interest Coverage 13.37
NYSE:CAH's Interest Coverage is ranked higher than
53% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.18 vs. NYSE:CAH: 13.37 )
Ranked among companies with meaningful Interest Coverage only.
NYSE:CAH' s Interest Coverage Range Over the Past 10 Years
Min: 5.89  Med: 13.99 Max: N/A
Current: 13.37
Piotroski F-Score: 5
Altman Z-Score: 4.65
Beneish M-Score: -2.52
WACC vs ROIC
7.64%
14.87%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating Margin % 1.85
NYSE:CAH's Operating Margin % is ranked lower than
62% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.78 vs. NYSE:CAH: 1.85 )
Ranked among companies with meaningful Operating Margin % only.
NYSE:CAH' s Operating Margin % Range Over the Past 10 Years
Min: 0.99  Med: 1.59 Max: 2.11
Current: 1.85
0.99
2.11
Net Margin % 1.06
NYSE:CAH's Net Margin % is ranked lower than
66% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.86 vs. NYSE:CAH: 1.06 )
Ranked among companies with meaningful Net Margin % only.
NYSE:CAH' s Net Margin % Range Over the Past 10 Years
Min: 0.33  Med: 1.18 Max: 2.22
Current: 1.06
0.33
2.22
ROE % 20.59
NYSE:CAH's ROE % is ranked higher than
87% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.36 vs. NYSE:CAH: 20.59 )
Ranked among companies with meaningful ROE % only.
NYSE:CAH' s ROE % Range Over the Past 10 Years
Min: 5.47  Med: 17.46 Max: 24.34
Current: 20.59
5.47
24.34
ROA % 3.95
NYSE:CAH's ROA % is ranked higher than
51% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.95 vs. NYSE:CAH: 3.95 )
Ranked among companies with meaningful ROA % only.
NYSE:CAH' s ROA % Range Over the Past 10 Years
Min: 1.33  Med: 4.49 Max: 8.29
Current: 3.95
1.33
8.29
ROC (Joel Greenblatt) % 92.70
NYSE:CAH's ROC (Joel Greenblatt) % is ranked higher than
86% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 21.01 vs. NYSE:CAH: 92.70 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NYSE:CAH' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 19.21  Med: 48.04 Max: 124.13
Current: 92.7
19.21
124.13
3-Year Revenue Growth Rate 7.80
NYSE:CAH's 3-Year Revenue Growth Rate is ranked higher than
51% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 7.80 vs. NYSE:CAH: 7.80 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NYSE:CAH' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -3.2  Med: 12.6 Max: 27
Current: 7.8
-3.2
27
3-Year EBITDA Growth Rate 32.40
NYSE:CAH's 3-Year EBITDA Growth Rate is ranked higher than
85% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 8.50 vs. NYSE:CAH: 32.40 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
NYSE:CAH' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -11.7  Med: 5.3 Max: 32.4
Current: 32.4
-11.7
32.4
3-Year EPS without NRI Growth Rate 64.50
NYSE:CAH's 3-Year EPS without NRI Growth Rate is ranked higher than
95% of the 38 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.00 vs. NYSE:CAH: 64.50 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
NYSE:CAH' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -15.7  Med: 5.7 Max: 64.5
Current: 64.5
-15.7
64.5
GuruFocus has detected 3 Warning Signs with Cardinal Health Inc $NYSE:CAH.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NYSE:CAH's 10-Y Financials

Financials (Next Earnings Date: 2017-05-07 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

CAH Guru Trades in Q1 2016

Leucadia National 3,700 sh (New)
Jeremy Grantham 4,800 sh (New)
Paul Tudor Jones 4,433 sh (New)
Joel Greenblatt 238,494 sh (+3980.31%)
First Pacific Advisors 100,190 sh (+79.75%)
Ray Dalio 93,432 sh (+45.23%)
John Buckingham 15,829 sh (+4.30%)
Vanguard Health Care Fund 6,385,231 sh (unchged)
RS Investment Management Sold Out
Barrow, Hanley, Mewhinney & Strauss 5,838,381 sh (-0.13%)
Pioneer Investments 2,188,697 sh (-11.87%)
Steven Cohen 119,200 sh (-19.35%)
Jim Simons 67,300 sh (-88.72%)
» More
Q2 2016

CAH Guru Trades in Q2 2016

Arnold Van Den Berg 77,330 sh (New)
Scott Black 10,740 sh (New)
Paul Tudor Jones 23,853 sh (+438.08%)
Joel Greenblatt 768,372 sh (+222.18%)
Barrow, Hanley, Mewhinney & Strauss 12,520,106 sh (+114.44%)
Jim Simons 126,400 sh (+87.82%)
Ray Dalio 143,581 sh (+53.67%)
Vanguard Health Care Fund 6,385,231 sh (unchged)
Leucadia National Sold Out
Jeremy Grantham Sold Out
First Pacific Advisors 98,560 sh (-1.63%)
John Buckingham 15,551 sh (-1.76%)
Pioneer Investments 1,806,400 sh (-17.47%)
Steven Cohen 62,100 sh (-47.90%)
» More
Q3 2016

CAH Guru Trades in Q3 2016

Mairs and Power 2,891 sh (New)
Jim Simons 261,600 sh (+106.96%)
Scott Black 14,767 sh (+37.50%)
Barrow, Hanley, Mewhinney & Strauss 16,250,027 sh (+29.79%)
First Pacific Advisors 98,560 sh (unchged)
Vanguard Health Care Fund 6,385,231 sh (unchged)
Steven Cohen Sold Out
John Buckingham 15,490 sh (-0.39%)
Arnold Van Den Berg 76,190 sh (-1.47%)
Pioneer Investments 1,506,937 sh (-16.58%)
Joel Greenblatt 591,857 sh (-22.97%)
Ray Dalio 97,257 sh (-32.26%)
Paul Tudor Jones 3,095 sh (-87.02%)
» More
Q4 2016

CAH Guru Trades in Q4 2016

Seth Klarman 1,030,000 sh (New)
John Rogers 36,526 sh (New)
David Dreman 2,278 sh (New)
Paul Tudor Jones 7,600 sh (+145.56%)
Barrow, Hanley, Mewhinney & Strauss 21,364,753 sh (+31.48%)
Ray Dalio 124,000 sh (+27.50%)
John Buckingham 19,441 sh (+25.51%)
Arnold Van Den Berg 94,697 sh (+24.29%)
Scott Black 14,837 sh (+0.47%)
Vanguard Health Care Fund 6,385,231 sh (unchged)
Mairs and Power 2,891 sh (unchged)
First Pacific Advisors 98,560 sh (unchged)
Jim Simons Sold Out
Pioneer Investments 321,926 sh (-78.64%)
Joel Greenblatt 74,164 sh (-87.47%)
» More
» Details

Insider Trades

Latest Guru Trades with CAH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Distribution » Medical Distribution    NAICS: 424210    SIC: 5122
Compare:NYSE:MCK, NYSE:ABC, OTCPK:SHTDF, NAS:HSIC, OTCPK:SHPMY, NAS:PDCO, OTCPK:MAHLY, NYSE:PBH, NYSE:OMI, OTCPK:CLIGF, NYSE:PMC, OTCPK:SNYR, OTCPK:CTTH, OTCPK:NPHC, OTCPK:SCVM » details
Traded in other countries:CAH.Argentina, CLH.Germany,
Cardinal Health Inc is a healthcare services company. It provides pharmaceutical & medical products & services that help pharmacies, hospitals and other healthcare providers focus on patient care. It also provides medical products to patients in the home.

Cardinal Health is a major distributor of pharmaceuticals and medical supplies to pharmacies and hospitals. Its operations include procurement, packaging, inventory management, and logistics services. Its largest customer is CVS Health retail pharmacy operatons.

Top Ranked Articles about Cardinal Health Inc

Seth Klarman’s Top 5 High Dividend Stocks See Seth Klarman's top 5 highest yielding dividend stocks analyzed in detail.
(Published by Nicholas McCullum on March 19) Read more...
The 10 Best Dividend Aristocrats Using the 8 Rules of Dividend investing to find the 10 Best Dividend Aristocrats
The Dividend Aristocrats are a group S&P 500 that have each paid increasing dividends for 25+ consecutive years. Read more...
Healthcare Dividend Growth Stocks: Part 1 9 healthcare dividend growth stocks that appear reasonable or attractive today.
Introduction Read more...
Sometimes It Is Good to Buy the Biggest. But Should You Buy the Biggest Health Care Distribution Business? McKesson is a giant that has recently experienced a pullback. Does that make it a good prospect, or would its competitors be better opportunities?
Arnold Van Den Berg Buys Stake in Cardinal Health Stock may be overvalued according to Peter Lynch earnings line
During the second quarter, guru Arnold Van Den Berg (Trades, Portfolio) purchased a 77,330 stake in Cardinal Health (NYSE:CAH) at an average price of $79.76 per share. Cardinal Health is one of the largest health care supply chains in North America. The purchase had a 1.01% impact on Van Den Berg’s portfolio. Read more...

Ratios

vs
industry
vs
history
PE Ratio 19.51
CAH's PE Ratio is ranked higher than
61% of the 54 Companies
in the Global Medical Distribution industry.

( Industry Median: 20.89 vs. CAH: 19.51 )
Ranked among companies with meaningful PE Ratio only.
CAH' s PE Ratio Range Over the Past 10 Years
Min: 6.29  Med: 15.93 Max: 73.78
Current: 19.51
6.29
73.78
Forward PE Ratio 13.39
CAH's Forward PE Ratio is ranked higher than
76% of the 17 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.00 vs. CAH: 13.39 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 19.51
CAH's PE Ratio without NRI is ranked higher than
60% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 23.00 vs. CAH: 19.51 )
Ranked among companies with meaningful PE Ratio without NRI only.
CAH' s PE Ratio without NRI Range Over the Past 10 Years
Min: 9.98  Med: 18.56 Max: 74.54
Current: 19.51
9.98
74.54
Price-to-Owner-Earnings 15.58
CAH's Price-to-Owner-Earnings is ranked higher than
56% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: 17.38 vs. CAH: 15.58 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
CAH' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 6.22  Med: 15 Max: 49.62
Current: 15.58
6.22
49.62
PB Ratio 4.06
CAH's PB Ratio is ranked lower than
83% of the 54 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.49 vs. CAH: 4.06 )
Ranked among companies with meaningful PB Ratio only.
CAH' s PB Ratio Range Over the Past 10 Years
Min: 0.86  Med: 2.42 Max: 4.76
Current: 4.06
0.86
4.76
PS Ratio 0.21
CAH's PS Ratio is ranked higher than
87% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.22 vs. CAH: 0.21 )
Ranked among companies with meaningful PS Ratio only.
CAH' s PS Ratio Range Over the Past 10 Years
Min: 0.08  Med: 0.17 Max: 0.32
Current: 0.21
0.08
0.32
Price-to-Free-Cash-Flow 15.54
CAH's Price-to-Free-Cash-Flow is ranked higher than
59% of the 29 Companies
in the Global Medical Distribution industry.

( Industry Median: 17.37 vs. CAH: 15.54 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
CAH' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 5.81  Med: 11.78 Max: 31.72
Current: 15.54
5.81
31.72
Price-to-Operating-Cash-Flow 12.00
CAH's Price-to-Operating-Cash-Flow is ranked higher than
52% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.26 vs. CAH: 12.00 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
CAH' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 4.68  Med: 10.14 Max: 19.4
Current: 12
4.68
19.4
EV-to-EBIT 12.43
CAH's EV-to-EBIT is ranked higher than
61% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.44 vs. CAH: 12.43 )
Ranked among companies with meaningful EV-to-EBIT only.
CAH' s EV-to-EBIT Range Over the Past 10 Years
Min: 5.2  Med: 11.6 Max: 25.5
Current: 12.43
5.2
25.5
EV-to-EBITDA 9.67
CAH's EV-to-EBITDA is ranked higher than
72% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.11 vs. CAH: 9.67 )
Ranked among companies with meaningful EV-to-EBITDA only.
CAH' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.5  Med: 9.5 Max: 17.6
Current: 9.67
4.5
17.6
PEG Ratio 1.52
CAH's PEG Ratio is ranked higher than
72% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.19 vs. CAH: 1.52 )
Ranked among companies with meaningful PEG Ratio only.
CAH' s PEG Ratio Range Over the Past 10 Years
Min: 1.19  Med: 3.97 Max: 25.19
Current: 1.52
1.19
25.19
Shiller PE Ratio 24.65
CAH's Shiller PE Ratio is ranked higher than
67% of the 18 Companies
in the Global Medical Distribution industry.

( Industry Median: 32.11 vs. CAH: 24.65 )
Ranked among companies with meaningful Shiller PE Ratio only.
CAH' s Shiller PE Ratio Range Over the Past 10 Years
Min: 6.64  Med: 13.65 Max: 28.92
Current: 24.65
6.64
28.92
Current Ratio 1.10
CAH's Current Ratio is ranked lower than
77% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.57 vs. CAH: 1.10 )
Ranked among companies with meaningful Current Ratio only.
CAH' s Current Ratio Range Over the Past 10 Years
Min: 1.1  Med: 1.34 Max: 1.83
Current: 1.1
1.1
1.83
Quick Ratio 0.53
CAH's Quick Ratio is ranked lower than
85% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.03 vs. CAH: 0.53 )
Ranked among companies with meaningful Quick Ratio only.
CAH' s Quick Ratio Range Over the Past 10 Years
Min: 0.53  Med: 0.66 Max: 1.15
Current: 0.53
0.53
1.15
Days Inventory 33.49
CAH's Days Inventory is ranked higher than
63% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 43.03 vs. CAH: 33.49 )
Ranked among companies with meaningful Days Inventory only.
CAH' s Days Inventory Range Over the Past 10 Years
Min: 25.37  Med: 30.84 Max: 35.34
Current: 33.49
25.37
35.34
Days Sales Outstanding 21.61
CAH's Days Sales Outstanding is ranked higher than
87% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 59.21 vs. CAH: 21.61 )
Ranked among companies with meaningful Days Sales Outstanding only.
CAH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 19.16  Med: 21.57 Max: 23.22
Current: 21.61
19.16
23.22
Days Payable 57.03
CAH's Days Payable is ranked lower than
58% of the 38 Companies
in the Global Medical Distribution industry.

( Industry Median: 65.77 vs. CAH: 57.03 )
Ranked among companies with meaningful Days Payable only.
CAH' s Days Payable Range Over the Past 10 Years
Min: 35.78  Med: 41.78 Max: 57.03
Current: 57.03
35.78
57.03

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 2.12
CAH's Dividend Yield % is ranked higher than
67% of the 57 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.88 vs. CAH: 2.12 )
Ranked among companies with meaningful Dividend Yield % only.
CAH' s Dividend Yield % Range Over the Past 10 Years
Min: 0.45  Med: 1.86 Max: 2.66
Current: 2.12
0.45
2.66
Dividend Payout Ratio 0.42
CAH's Dividend Payout Ratio is ranked lower than
58% of the 33 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.28 vs. CAH: 0.42 )
Ranked among companies with meaningful Dividend Payout Ratio only.
CAH' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.19  Med: 0.33 Max: 1.12
Current: 0.42
0.19
1.12
3-Year Dividend Growth Rate 13.90
CAH's 3-Year Dividend Growth Rate is ranked higher than
56% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.70 vs. CAH: 13.90 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
CAH' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 12.2  Med: 17 Max: 49.4
Current: 13.9
12.2
49.4
Forward Dividend Yield % 2.20
CAH's Forward Dividend Yield % is ranked higher than
66% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.88 vs. CAH: 2.20 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 4.36
CAH's 5-Year Yield-on-Cost % is ranked higher than
59% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.94 vs. CAH: 4.36 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
CAH' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.92  Med: 3.82 Max: 5.47
Current: 4.36
0.92
5.47
3-Year Average Share Buyback Ratio 1.70
CAH's 3-Year Average Share Buyback Ratio is ranked higher than
89% of the 35 Companies
in the Global Medical Distribution industry.

( Industry Median: -1.40 vs. CAH: 1.70 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CAH' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -21.6  Med: 1.4 Max: 5.7
Current: 1.7
-21.6
5.7

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 1.17
CAH's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
71% of the 35 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.60 vs. CAH: 1.17 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
CAH' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.29  Med: 0.94 Max: 5.4
Current: 1.17
0.29
5.4
Price-to-Median-PS-Value 1.22
CAH's Price-to-Median-PS-Value is ranked lower than
73% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.05 vs. CAH: 1.22 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
CAH' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.49  Med: 1.53 Max: 3.07
Current: 1.22
0.49
3.07
Price-to-Peter-Lynch-Fair-Value 1.43
CAH's Price-to-Peter-Lynch-Fair-Value is ranked higher than
63% of the 19 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.90 vs. CAH: 1.43 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
CAH' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.49  Med: 1.37 Max: 11.92
Current: 1.43
0.49
11.92
Earnings Yield (Greenblatt) % 8.04
CAH's Earnings Yield (Greenblatt) % is ranked higher than
67% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.35 vs. CAH: 8.04 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
CAH' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 3.9  Med: 8.6 Max: 19
Current: 8.04
3.9
19
Forward Rate of Return (Yacktman) % 20.19
CAH's Forward Rate of Return (Yacktman) % is ranked higher than
69% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.30 vs. CAH: 20.19 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
CAH' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 4.3  Med: 10.4 Max: 21.2
Current: 20.19
4.3
21.2

More Statistics

Revenue (TTM) (Mil) $127,235
EPS (TTM) $ 4.17
Beta0.85
Short Percentage of Float3.18%
52-Week Range $62.70 - 87.85
Shares Outstanding (Mil)315.45

Analyst Estimate

Jun17 Jun18 Jun19
Revenue (Mil $) 130,963 139,089 145,270
EPS ($) 5.39 6.02 6.48
EPS without NRI ($) 5.39 6.02 6.48
EPS Growth Rate
(Future 3Y To 5Y Estimate)
12.66%
Dividends per Share ($) 1.73 1.67 1.42
» More Articles for CAH

Headlines

Articles On GuruFocus.com
Seth Klarman’s Top 5 High Dividend Stocks Mar 21 2017 
Why I Prefer Cardinal Health Over AmerisourceBergen Mar 17 2017 
Scott Black Continues to Buy Allergan, CVS Health, 6 Others Mar 16 2017 
Seth Klarman's Largest 4th-Quarter Buys Mar 16 2017 
Joel Greenblatt Cuts Hewlett Packard, Walt Disney, Oracle Mar 06 2017 
Beaten-Down Valuation and a 3% Dividend Yield Feb 07 2017 
2 Top Health Care Dividend Stocks Jan 12 2017 
Top 7 Dividend Health Care Stocks Jan 05 2017 
Integer Investments: Drug Distributors Are Good Investments Jan 04 2017 
Bargain Hunting: The 10 Worst-Performing Dividend Achievers of 2016 Jan 01 2017 

More From Other Websites
Why I Prefer Cardinal Health Over AmerisourceBergen Mar 17 2017
Why Navidea can recover no more than $12M if it wins against ex-lender in court Mar 13 2017
Why Is Cardinal Health (CAH) Up 4.4% Since the Last Earnings Report? Mar 10 2017
Connecting Career Potential and Company Leadership Earned Cardinal Health Distinction from National... Mar 08 2017
Navidea closes Lymphoseek sale to Cardinal Health; lender CRG accepts loan payment, drops liens Mar 06 2017
Cardinal Health, Inc. : CAH-US: Dividend Analysis : January 03rd, 2017 (record date) : By the... Feb 24 2017
Cardinal Health helps Navidea settle lender's payoff – for now Feb 24 2017
Survey Finds Hospital Staff Report Better Supply Chain Management Leads to Better Quality of Care... Feb 15 2017
Stock Research Reports for Union Pacific, ConocoPhillips & Emerson Electric Feb 14 2017
ETFs with exposure to Cardinal Health, Inc. : February 14, 2017 Feb 14 2017
CARDINAL HEALTH INC Financials Feb 11 2017
Top Analyst Reports for Morgan Stanley, GM & Prudential Feb 10 2017
5 Stocks For 17% Returns This Year (& Beyond) Feb 09 2017
Cardinal Health, Inc. :CAH-US: Earnings Analysis: Q2, 2017 By the Numbers : February 8, 2017 Feb 08 2017
Cardinal Health CEO George Barrett elected to lead corporate health-policy group Feb 07 2017
Edited Transcript of CAH earnings conference call or presentation 7-Feb-17 1:30pm GMT Feb 07 2017
UPDATE 2-Cardinal Health revenue misses on generic drug pricing pressure Feb 07 2017
Cardinal Health profit beats estimates on lower costs Feb 07 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)